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t(2;11)(q31;p15) is an example of a variant 
translocation involving NUP98 gene at 11p15 which is 
fused with HOXD13 gene at 2q31.  
This fusion produces a chimeric protein with 
leukemogenic activity. t(2;11)(q31;p15) is associated 
with myeloid malignancies. 
 
Clinics and pathology 
Disease 
t(2;11)(q31;p15) is a rare but nonrandom translocati n, 
reported in de novo acute myeloid leukemia (AML) as 
well as therapy related myelodysplastic 
syndrome/therapy related acute myeloid leukemia (t-
MDS/t-AML), and one case of chronic myeloid 
leukemia in blast crisis (CML-BC). 
 
Partial ideogram and G-banded karyotypes showing t(2;11)(q31;p15); arrows indicate breakpoints. 
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Phenotype/cell stem origin 
Mostly AML-M4; bone marrow displaying monocytic 
features; AML-M6 in one case. 
Epidemiology 
Generally the incidence of NUP98 rearrangements in 
leukemia is difficult to estimate probably 1-2% of 
AML cases.  
The t(2;15)(q32;p15) is rare; around 8 cases in 
literature; reported in male and female with 1:1 ratio; 
Infants under the age of a year; children (10-15 years) 
as well as adults (59-62 years); over-representatio in 
Asian race in particular Japanese. 
It has been shown that NUP98/11p15 is a frequent 
target for chromosomal rearrangements following 
chemotherapies with DNA topoisomerase II inhibitors.  
Interestingly, there are at least three infants leukemia 
with NUP98-HOXD13 gene fusion. It has been 
suggested that a high intake of certain diets rich in 
flavonoids during pregnancy increases the risk of infant 
leukemia due to the inhibition effect on topo II activity.  
It is worth to mention that in one infant, the NUP98-
HOXD13 gene fusion was demonstrated 
retrospectively in neonatal blood spot. This provides 
strong evidence that the fusion is a prenatal event. 
Clinics 
Peripheral blood; High white cell counts (WBC) with 
elevated monocytes; low platelets;  
Bone Marrow: Hypercellular marrow with monocytic 
differentiation;  
Immunophenotypes; Cell surface marker expression 
included CD13, CD14, CD33, CD34, HLA-DR, 
CD11b, CD65. 
Prognosis 
Due to rarity of t(2;11) leukemia, it is difficult o 
determine the prognostic significance of this 
translocation in leukemia.  
However, all de novo t(2;11) AML achieved remission, 
while patients with t-AML progressed rapidly. 
Generally, NUP98 gene fusion in leukemia predicts 
poor clinical outcome. 
Cytogenetics 
Cytogenetics morphological 
Sole Anomaly; t(2;11)(q31;p15) was a sole anomaly in 
5/8 cases. 
Additional anomalies 
Trisomy 8 in one case; balanced translocations in one 
case; in a CML-BC case t(2;11)(q31;p15) was 
secondary to Ph chromosome. 
Variants 
t(2;11;9)(q31;p15;q22)/NUP98-HOXD13 fusion in one 
case. 
 
Genes involved and proteins 




HOXD11 and HOXD13 genes, located on chromosome 
2q31, are member of a large family of developmental 
homeobox genes. Homeobox genes encode 
evolutionarily conserved transcription factors that 
appear to be involved in body plan formation and 
embryonic development, and also play a critical role in 
limb development. 









NUP98 gene, located on chromosome 11p15, encodes a 
98-KD protein a component of nuclear pore complex 
(NPC). NUP98 is found in the nucleoplasmic and 
cytoplasmic domains of the NPC, and functions as a 
transport co-factor of RNA and protein between the 
nucleus and cytoplasm. In addition, NUP98 appear to 
be involved in mitotic spindle formation and in cell 
cycle progression. Haploinsufficiency of NUP98 gene 
has been shown to cause premature separation of sister 
chromatids leading to sever aneuploidy. 
In leukemia, there are at least 29 different partner genes 
fused with NUP98, 50% of which are homeobox genes. 
Different genes are likely associated with different 
leukemic phenotypes. 




5'-NUP98-HOXD13-3' fusion is the oncogeneic 
product of the t(2;11); exon 12 of NUP98 gene is fused 
in-frame with exon 2 of HOXD13 gene. 
Fusion protein 
Description 
NUP98 fusion gene encodes a chimeric protein which 
is the amino terminal portion of NUP98 protein fuses 
the carboxyl portion of the partner gene HOXD13. The 
fused protein acts as an aberrant transcription factor. 
Several studies have demonstrated that NUP98- 
HOXD13 fusion protein blocks differentiation of 
hematopoietic precursor cells, and has aberrant self-
renewal capacity. 
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